Paraplegics use virtual reality to reduce phantom pain

Scientists at École Polytechnique Fédérale de Lausanne, Switzerland have demonstrated that phantom body pain in paraplegic patients could be reduced by creating a bodily illusion using virtual reality (VR), according to a study published Neurology.

Even without their legs, many paraplegics suffer from phantom neuropathic pain due to spinal cord lesions. In this study, led by neuroscientist Olaf Blanke, researchers evaluated the effect of VR in helping create an illusion and reducing phantom pain.

The study used a pair of fake legs, a camera, VR googles and rods to create the illusion. The legs were filmed in real-time and displayed in VR googles worn by a patient so he would view the legs from above. Researchers then tapped the patient's back with one rod while also tapping the dummy legs with another.

"We tapped the back of the subject near the shoulders and the subject experienced the illusion that the tapping originated from the paralyzed legs," explained Polona Poeg, co-author of the study and a neuroscientist at the Lausanne University Hospital (CHUV). "This is because the subject also received visual stimuli of dummy legs being tapped, viewed through the virtual reality headset, so the subject saw them immersivily as his or her own legs."

"We managed to provoke an illusion: The illusion that the subject's legs were being lightly tapped, when in fact the subject was actually being tapped on the back, above the spinal cord lesion," said Blanke. "When we did this, the subjects also reported that their pain had diminished."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.